We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Industry

Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

C2N Diagnostics and LSI Medience have partnered to seek approval and commercialize the PrecivityAD2 test in Japan. More...
11 Nov 2026
Image: Siemens Healthineers has begun carving out its in vitro diagnostics business as a standalone company named Olyrian Diagnostics (Photo courtesy of Siemens Healthineers)

Siemens Healthineers Begins Transition Toward Standalone Olyrian Diagnostics Business

Siemens Healthineers has initiated the carve-out of its in vitro diagnostics business, which will operate as Olyrian Diagnostics. More...
06 Nov 2026
Image: The acquisition of Proscia advances Agilent’s efforts to expand its pathology portfolio and strengthens its competitive position in a rapidly growing market.

Agilent Completes Acquisition of Digital Pathology Platform Developer Proscia

Agilent Technologies has completed its acquisition of Proscia, a provider of digital pathology software for clinical and life sciences applications. More...
06 Nov 2026
Image: Onvaro’s commercial portfolio will be anchored by the binx io platform, an FDA-cleared, CLIA-waived molecular point-of-care system with more than 1,000 installed instruments. (Photo courtesy of binx health)

New Diagnostics Company Onvaro Formed to Expand Decentralized Testing

The combination brings together two diagnostics platforms to create a connected point-of-need testing platform. More...
06 Nov 2026
Image: SG-INSIGHT study will extend whole- genome sequencing to nearly 1 in 10 Singapore residents, generating evidence to inform how precision medicine could be implemented in Singapore’s healthcare system. (Photo courtesy of Precision Health Research, Singapore)

Illumina Selected to Support National Genomics Study for Personalized Healthcare in Singapore

Illumina has been selected to provide whole-genome sequencing for SG-INSIGHT, under Singapore’s National Precision Medicine program. More...
04 Nov 2026
Image: The ExaccType ESR1 dPCR Kit uses digital PCR technology to detect key ESR1 mutations associated with acquired resistance to endocrine therapy. (Photo courtesy of  BIOTYPE)

Collaboration Expands Access to Tests for Cancer Treatment Resistance and Toxicity Risk

A new collaboration brings ESR1 and DPYD testing solutions developed by APIS Assay Technologies to market under BIOTYPE’s ExaccType brand.  More...
03 Nov 2026
Image: AVITI Dx is a Class A IVD sequencing system supported by IVDR-compliant reagents and software, designed to deliver high-quality sequencing with flexibility and scalability for decentralized diagnostics (Photo courtesy of Element Biosciences)

CE-Marked IVD Sequencing Platform Launches Across Ten EU Countries

Element Biosciences has commercially launched AVITI Dx, its first CE-marked IVD sequencing platform under the European Union’s IVDR.  More...
30 Oct 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2026 Globetech Media. All rights reserved.